Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stelitano

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Ultrasound|April 24, 2020
Carpal tunnel sonographyA Gervasio, C Stelitano, P Bollani, et al.
Haematologica|September 8, 1999
In vitro drug-induced cytotoxicity predicts clinical response to high-dose chlorambucil in B-cell chronic lymphocytic leukemiaV Callea, C Stelitano, I Callea, et al.
Tumori|February 28, 1991
Diagnostic and prognostic relevance of the immunophenotype in acute myelocytic leukemiaV Callea, F Morabito, B Martino, et al.
Mediators of Inflammation|March 17, 2005
Lipid peroxidation and protein oxidation in patients affected by Hodgkin's lymphomaF Morabito, M Cristani, A Saija, et al.
Haematologica|December 29, 1998
Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL)V Callea, V Clò, F Morabito, et al.
Leukemia Research|October 13, 2001
Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemiaF Morabito, M Mangiola, B Oliva, et al.
Haematologica|May 1, 1996
In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic featuresF Morabito, C Stelitano, I Callea, et al.
Haematologica|July 1, 1996
Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemiaV Callea, F Morabito, F Luise, et al.
Leukemia|March 1, 1993
Alpha 2-interferon in B-cell chronic lymphocytic leukemia: clinical response, serum cytokine levels, and immunophenotype modulationF Morabito, V Callea, B Oliva, et al.
Haematologica|May 9, 1998
Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei LinfomiF Merli, M Federico, P Avanzini, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Ultrasound|April 24, 2020
Carpal tunnel sonographyA Gervasio, C Stelitano, P Bollani, et al.
Haematologica|September 8, 1999
In vitro drug-induced cytotoxicity predicts clinical response to high-dose chlorambucil in B-cell chronic lymphocytic leukemiaV Callea, C Stelitano, I Callea, et al.
Tumori|February 28, 1991
Diagnostic and prognostic relevance of the immunophenotype in acute myelocytic leukemiaV Callea, F Morabito, B Martino, et al.
Mediators of Inflammation|March 17, 2005
Lipid peroxidation and protein oxidation in patients affected by Hodgkin's lymphomaF Morabito, M Cristani, A Saija, et al.
Haematologica|December 29, 1998
Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL)V Callea, V Clò, F Morabito, et al.
Leukemia Research|October 13, 2001
Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemiaF Morabito, M Mangiola, B Oliva, et al.
Haematologica|May 1, 1996
In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic featuresF Morabito, C Stelitano, I Callea, et al.
Haematologica|July 1, 1996
Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemiaV Callea, F Morabito, F Luise, et al.
Leukemia|March 1, 1993
Alpha 2-interferon in B-cell chronic lymphocytic leukemia: clinical response, serum cytokine levels, and immunophenotype modulationF Morabito, V Callea, B Oliva, et al.
Haematologica|May 9, 1998
Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei LinfomiF Merli, M Federico, P Avanzini, et al.
Pageof 3